Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company

argenx clinical trials

The registry lists 93 studies whose lead sponsor is argenx or one of 1 company grouped under it. 35 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Keep track of what changes. Save the argenx studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed: 36
Recruiting: 26
Active, not recruiting: 13
Terminated: 8
Not yet recruiting: 6
Enrolling by invitation: 2

Phase

Phase 2: 35
Phase 3: 33
Phase 1: 22
Phase 4: 2

Where

United States: 56
Spain: 43
Germany: 43
Italy: 43
Poland: 41
Belgium: 37

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to argenx.

argenx
Same company
Something wrong?
What is wrong with this name?A different company with a similar name, not argenxargenx is owned by another companySomething else
What is right?A source, if you have one
No account needed. Please leave out personal details.
87 studies
Forte Biosciences, Inc.
Acquired — became part of argenx, Aug 27, 2026 · source ↗
Something wrong?
What is wrong with this name?Not part of argenxWrong relationship to argenxWrong dateSource is wrong or brokenSomething else
What is right?A source, if you have one
No account needed. Please leave out personal details.
6 studies →

Focus areas

Conditions argenx leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Myasthenia Gravis17

Studies

Recruiting first, then most recently updated. Showing 50 of 93. Browse all 93 →